Background: Pulsed radiofrequency (PRF) application to the dorsal root ganglia can reduce neuropathic pain (NP) in animal models, but the effect of PRF on damaged peripheral nerves has not been examined. We investigated the effect of PRF to the rat sciatic nerve (SN) on pain-related behavior and SN ultrastructure following chronic constriction injury (CCI). Methods: The analgesic effect was measured by hindpaw mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL). Twenty rats with NP induced by ligating the common SN were then randomly divided into a PRF treatment group and a sham group. The contralateral SN served as a control. The MWT and TWL were determined again 2, 4, 6, 8, 10, 12, and 14 days after the PRF or sham treatment. On day 14, ipsilateral and contralateral common SNs were excised and examined by electron microscopy. Results : Ipsilateral MWT was signifi cantly reduced and TWL signifi cantly shorter compared to the contralateral side 14 days after CCI (both P = 0.000). In the PRF group, MWT was signifi cantly higher and TWL signifi cantly longer 14 days after the PRF treatment compared to before PRF treatment (both P = 0.000), while no such difference was observed in the sham group (P > 0.05). Electron microscopy revealed extensive demyelination and collagen fi ber formation in the ipsilateral SN of sham-treated rats but sparse demyelination and some nerve fi ber regrowth in the PRF treatment group. Conclusions: Hyperalgesia is relieved, and ultrastructural damage ameliorated after direct PRF treatment to the SN in the CCI rat model of NP. 
INTRODUCTION
Conventional radiofrequency thermocoagulation is a clinically effective treatment for reducing neuropathic pain (NP). However, the heat generated inevitably causes damage to the target neural tissue and may also injure adjacent tissue . [1] Pulsed radiofrequency (PRF), a technique fi rst described by Sluijter in 1997, can reduce the risk of nerve injury [2] by providing pulses of high frequency current with heat dissipation between pulses.
The PRF is applied by a radiofrequency generator producing alternating output voltage of 45 V at 500 kHz. The target neural tissue is stimulated by an electrode positioned at the target site under fl uoroscopy or other guidance methods.
An alternating current is applied at a pulse frequency of 2 Hz, with each pulse lasting 20 ms followed by a 480 ms interval. Since the output is interrupted, heat is allowed to dissipate so that the temperature at the electrode tip never exceeds 42°C. Consequently, destruction of surrounding tissue and the postoperative damage to adjacent nervous tissue are avoided. [3, 4] Novel PRF techniques have been used successfully to treat multiple chronic pain conditions, [5] [6] [7] [8] [9] [10] [11] [12] including joint pain, myofascial pain, and neuralgia. Although complications and side effects are generally less common compared to radiofrequency thermocoagulation, PRF is not as effective as radiofrequency thermocoagulation for relief of certain forms of neuralgia, such as trigeminal neuralgia. [13, 14] It is, therefore, necessary to conduct additional laboratory studies and clinical trials to improve the effi cacy of PRF further.
Pulse radiofrequency application is also effective in animal models of NP. For example, Aksu et al. applied PRF to the L5 and L6 dorsal root ganglia (DRG) of a rabbit NP model and found that mechanical and thermal hyperalgesia were signifi cantly reduced 2-3 weeks after treatment, [15] while Perret et al. reported that PRF to the L5 DRG of a rat NP model reversed allodynia as measured by behavior testing. [16] However, all previous studies [15] [16] [17] [18] [19] have employed DRG stimulation while the effects of PRF on the damaged peripheral nerve are largely unknown. However, the treatment focusing on the injury part of the nerve was reported recently. [20] In this study, we established a rat peripheral NP model using chronic constriction injury (CCI) of the sciatic nerve (SN) and investigated the effect of PRF to the SN on analgesia and SN ultrastructure by behavioral pain testing and electron microscopy.
METHODS
Twenty male Sprague Dawley rats (4 months old, 200-220 g) were obtained from Vital River Laboratories, Beijing. Animals were housed under a 12-h light-dark cycle at 22-24°C with ad libitum access to food and water in the Experimental Animal Center of Beijing Neurosurgical Institute (SPF class). All procedures used in this study were approved by the Beijing Neurosurgical Institute Experimental Animal Welfare Ethics Committee.
Neuropathic lesions and blocking
The CCI model was established by ligation of the right SN as described by Bennett and Xie. [21] Rats that developed hyperalgesia 14 days after CCI surgery as determined by behavioral testing were randomly divided into two groups of 10, one group to receive PRF treatment to the ligated common SN and another to receive sham treatment. The contralateral hindpaw response served as a control for these studies.
Pulsed radiofrequency treatment
The ligated SNs were exposed by blunt dissection through the biceps femoris. A trocar (PMF-21-50-2, Baylis Medical, Montreal, Canada) was placed close to the SN at the site of ligation. The stylet was withdrawn, and the PRF stimulating electrode (PMK-21-50, Baylis Medical) was introduced.
The exposed SNs of animals assigned to the PRF treatment group were treated with 2 Hz pulsed frequency current for 120 s at 42°C delivered by a radiofrequency generator (PMG-230, Baylis Medical). The animals assigned to the sham group underwent the same procedures, but no current was passed through the electrode.
Behavioral testing
Hindpaw mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) were measured using von Frey hairs and hot plate tests, respectively. Measurements were conducted on both ipsilateral (treated) and contralateral (untreated control) sides before CCI, on days 2, 4, 6, 8, 10, 12, and 14 after CCI, and on these same days after PRF or sham treatment.
Thermal withdrawal latency was measured by the hot plate test. A radiant heat source was positioned under the glass fl oor directly beneath the hindpaw of the test subject and latency from the heat onset to a brisk withdrawal (TWL) measured 3 times at 2-min intervals. The average TWL was recorded.
Electron microscopy
The common SNs from each rat were excised 14 days after PRF or sham treatment, fi xed in 2% glutaraldehyde plus 2% formaldehyde, and embedded in Epon. Ultrathin sections were prepared and stained with osmic acid for examination by transmission electron microscopy (HITACHI 7615, Japan).
Statistical analysis
All statistical analyses were performed using SPSS version 18.0, Chicago IL (SPSS Inc., USA). Differences in group means before and after treatment were evaluated for statistical significance by one-way analysis of variance (ANOVA). Within-group differences across time were evaluated by repeated measures ANOVA. A P < 0.05 was considered as statistically signifi cant.
RESULTS
The differences in MWT after CCI, PRF, and sham treatment are shown in Figures 1 and 2 . After ligation of the right (ipsilateral) common SN, the ipsilateral MWT gradually decreased. A sharp decrease was seen from day 4 (P = 0.001, Figure 1 ) after surgery and continued until day 14 (P = 0.000, Figure 1 ). From day 8-14 after PRF application, there was a signifi cant increase in MWT above that measured before the PRF treatment (P = 0.001, 0.000, Figure 1 : Hindpaw mechanical withdrawal threshold development following chronic constriction injury to the sciatic nerve. All measurement data that followed a normal distribution were expressed as the mean ± standard deviation. Differences in group means before and after treatment were evaluated for statistical significance by one-way analysis of variance (ANOVA). Within-group differences across time were evaluated by repeated measures ANOVA. A P < 0.05 was considered as statistically significant. R: Ipsilateral/ligated side; L: Contralateral/control side (*P < 0.05, **P < 0.01 vs. control).
0.000, and 0.000 respectively, Figure 2 ). On days 8, 10, 12, and 14 posttreatment, mean MWT was signifi cantly higher in the PRF group compared to the sham group (P = 0.001, 0.000, 0.000, and 0.000 respectively, Figure 2 ) although still slightly lower than the unligated control value (P = 0.000, 0.000, 0.000, and 0.024 respectively, Figure 2 ).
Changes in TWL mirrored the changes observed in MWT after CCI, PRF, or sham treatment that are shown in Figures 3 and 4 . From day 10 after PRF application, there was a marked increase in ipsilateral mean TWL compared to that before the PRF treatment (P = 0.000, Figure 4) . On days 10, 12, and 14 posttreatment, ipsilateral mean TWL was signifi cantly longer in the PRF group compared to the sham group (P = 0.000, 0.000, and 0.000 respectively, Figure 4) . Moreover, the ipsilateral mean TWL of the PRF group on day 14 was not signifi cantly different from the contralateral value (P > 0.05 on day 14, Figure 4 ).
The changes in SN ultrastructure following CCI, PRF, and sham treatment are shown in Figures 5-7 . SN ligation resulted in severe mechanical damage to axons and Wallerian degeneration as measured 14 days after sham treatment [ Figure 5a and b]. In contrast, ipsilateral SN fi bers from PRF-treated rats exhibited loosely arranged axon bundles [ Figure 6a and b] and the majority of myelinated and unmyelinated nerve fibers appeared normal. Most of the myelin sheaths retained structural integrity. The macrophages appeared in close proximity to nerve fi bers with severe myelin sheath lesions and contained engulfed necrotic tissue and cholesterol crystals while collagen fi bers were rarely seen. Abnormal features in PRF group axons included extensive mitochondrial hyperplasia with fragmented cristae and vacuole formation [ Figure 6c and d]. In contralateral SNs from both groups, the laminar-like structure of myelin sheaths was well-defined, and subcellular structures were clearly visible in both Schwann cells and axons. Mitochondrial swelling and hyperplasia were seldom observed in contralateral axons [ Figure 7a and b].
DISCUSSION
We used MWT and TWL as measures of mechanical and thermal pain threshold, respectively, to evaluate the effects of PRF on CCI-induced hyperalgesia. Both MWT and TWL were signifi cantly lower after CCI, indicative of hyperalgesia and induction of NP in an animal model. Marked improvement in NP was observed 10-14 days after PRF treatment. In contrast to previous reports, [15] [16] [17] [18] [19] this reversal of hyperalgesia resulted from direct SN stimulation rather than DRG stimulation. In clinical practice, PRF to the suprascapular nerve, [5, 6] occipital nerve, [7, 8] and other peripheral nerves [9] [10] [11] [12] has also shown clinical effi cacy, but no animal models had been established to examine the mechanisms suppressing hyperalgesia. The current results also indicate that the effect of direct PRF treatment on the SN is relatively slow in onset (around 10 days). On the other hand, post-PRF MWT values did not return to control (unligated side) values 14 days after PRF treatment, suggesting that PRF cannot completely reverse hyperalgesia within 2 weeks. However, the incremental changes in MWT 10-14 days after PRF application suggest that a complete amelioration of NP is possible given suffi cient time.
The NP can be developed by constriction of the SN with a pathologic basis of demyelination. Our electron microscopic observations revealed that PRF did appear to partially ameliorate the severe damage induced by CCI. That is, PRF-treated SNs exhibited less severe demyelination, fi brosis, and Schwann cell proliferation than SNs from sham-treated rats. These results suggest that PRF can facilitate restoration of normal nerve structure in parallel with the restoration of function (reversal of CCI-induced hyperalgesia).
The ultrastructural changes observed in the SN after PRF included extensive mitochondrial swelling and hyperplasia [ Figure 6c ] while no mitochondrial swelling and hyperplasia were observed in sham or control SNs. Given the functional recovery observed, it is likely that the mitochondrial hyperplasia is a compensatory response that aids in recovery and regeneration of damaged nerve fi bers. We also observed macrophages containing engulfed necrotic tissue and cholesterol crystals in PRF group nerves [ Figure 6d ] while few macrophages were seen in sham group or control nerves. These results suggest that PRF promotes infi ltration of infl ammatory cells to clear tissue debris and allow for regenerative processes to reverse the effects of compression injury. It should be noted, however that these are relatively early responses, and additional studies are required to assess the long-term effects of PRF on the ultrastructure of injured peripheral nerves.
Application of PRF to the DRG is an effective therapy for reducing pain in rat and rabbit models of NP. [15] [16] [17] [18] [19] In this study, we demonstrated for the fi rst time that the common SN is also a feasible therapeutic target. Application of PRF to the SN relieved hyperalgesia in a CCI animal model and restored nerve ultrastructure damaged by CCI. Thus, peripheral nerve entrapment syndromes, such as piriformis syndrome and carpal tunnel syndrome, may be treatable by direct PRF.
Pulsed radiofrequency treatment is a variation of conventional radiofrequency thermocoagulation but offers several unique advantages, including minimal invasiveness, ease of application and greater safety. [22] Indeed, the lower heat emission greatly reduces the risk of nerve damage. Nonetheless, several NP-like conditions are poorly responsive to PRF, so further investigation is needed to optimize PRF effi cacy and determine the ideal therapeutic strategy.
The mechanisms of PRF action are still unclear, but it is known that changes of c-Fos, ATF3 expression and levels of local inflammatory factors are involved after PRF treatment. [23] We propose that PRF to the SN relieves NP by altering the peripheral nerve both functionally and structurally. However, elucidation of the molecular mechanisms mediating the analgesic effects of PRF on peripheral NP requires much further study.
This study evaluated the effects of PRF over only 14 days, and the late onset and slow reversal of CCI-induced hyperalgesia suggested that the repair may continue for a longer period. Second, we did not compare the effi cacy of PRF to the SN with that on other nerves. Furthermore, more studies are needed to fi nd out the optimal parameters of PRF treatment in the future.
Our results provide preliminary evidence that PRF may reduce NP when applied directly to the injured nerve. Effects of PRF may vary in different pain models, an issue that requires much further investigation.
